Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

TMTMED
5 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in T ROWE PRICE EXCHANGE-TRADED

CITADEL ADVISORS LLC holds 5,958 shares of TMED (T ROWE PRICE EXCHANGE-TRADED), worth $203,482 as of 2026-Q2. The position was decreased (-91.1% shares).

Current Value

$203,482

Current Shares

5,958

Total Value Change

-$34,377

Total Shares Change

-3,627

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5,958
-91.1%
$203,4820.0%$34.15
0
2026-Q1
Increased
66,660
+141.5%
$1.9M0.0%$29.80
42
2025-Q4
Decreased
27,601
-7.3%
$820,3900.0%$29.76
0
2025-Q3
Increased
29,774
+210.6%
$794,3410.0%$25.95
40
2025-Q2
New
9,585
-
$237,8590.0%$24.56
35

Other major holders of TMED: COMMONWEALTH EQUITY SERVICES, LLC, UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used